Bullish
Humana (NYSE: HUM) reported strong first-quarter 2026 financial results, with GAAP EPS of $9.83 and Adjusted EPS of $10.31, meeting the high end of th...
Neutral
AMG National Trust Bank reduced its stake in Humana Inc. by 42.4% in the fourth quarter, selling 7,189 shares, leaving them with 9,764 shares valued a...
Humana (NYSE:HUM) is set to report its Q1 earnings tomorrow, with expectations for 22.9% year-on-year revenue growth. The company reported a significa...
Bullish
Humana Inc (HUM) shares rose 3.9% but are down over the past year. Despite recent gains, the stock is considered significantly undervalued by GuruFocu...
Neutral
Cwm LLC significantly reduced its stake in Humana Inc. by 56.1% in the fourth quarter, selling 9,178 shares and retaining 7,172 shares valued at $1.84...
Neutral
Humana Inc. (NYSE:HUM) has received a consensus "Hold" recommendation from twenty-six analysts, with an average 12-month price target of $222.09. Rece...
Neutral
Humana Inc. (NYSE:HUM) experienced a 19.3% increase in short interest in March, reaching 5,937,118 shares, representing 5.0% of the stock sold short. ...
Lupin's US subsidiary has agreed to pay Humana Inc. $30 million to resolve an antitrust lawsuit, part of the consolidated In Re Generic Pharmaceutical...
Neutral
Lupin Limited's US subsidiary, Lupin Pharmaceuticals Inc., has settled an antitrust dispute with Humana Inc. for $30 million. The subsidiary denies al...
Lupin's U.S. arm, Lupin Pharmaceuticals Inc., has agreed to a $30 million settlement with Humana Inc. to resolve an antitrust lawsuit. This settlement...
Neutral
Lupin Pharmaceuticals, Inc. USA (LPI), a wholly-owned subsidiary, has entered into a $30 million settlement agreement with Humana Inc. to resolve anti...
Neutral
Lupin's U.S. subsidiary, Lupin Pharmaceuticals, Inc., has settled an antitrust lawsuit with Humana Inc. for $30 million. This settlement resolves alle...
Bullish
Humana Inc. (HUM) announced a consistent quarterly dividend of $0.885 per share, marking the fourteenth consecutive quarter at this level. The dividen...
Neutral
Humana has appointed Robert S. Field, principal and managing member of ηMed Capital Management, to its board of directors. Field's extensive expertise...
Neutral
Humana Inc. announced the election of Robert S. Field, principal and managing member of ηMed Capital Management LLC, to its board of directors. Field ...
Bullish
Humana Inc. (HUM) has expanded its Board of Directors from ten to eleven members, effective April 16, 2026, with the appointment of Robert S. Field as...
Bullish
Humana Inc. (HUM) announced the appointment of Robert Field to its Board of Directors, a strategic move to enhance its healthcare sector expertise. Fi...